Patients with luminal breast cancer with Ki-67 below 14% and intermediate between 14 and 19% had the same disease-free interval and disease-specific survival and a better prognosis when compared to patients with Ki-67 above 20% [41]. Here, MKI67 is linked to breast cancer.